OD260 Inc

OD260 Inc is your ideal partner for the pre-clinical development of oncolytic adenovirus vectors. With more than 20 years experience in the field, we will help you with the design and construction of your vector and the generation of validated virus stocks for in vitro and animal studies (up to 10¹⁵ VP). QC tests include confirmation of virus identity (genome sequencing), physical and infectious titer (VP/IU), genetic and thermal stability, and verification of transgene expression.